[Nonsteroidal anti-inflammatory agents in pediatrics (2)].
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D001477:Bartter Syndrome / Q000188:drug therapy; D056486:Chemical and Drug Induced Liver Injury; D002648:Child; D002675:Child, Preschool; D004066:Digestive System Diseases / Q000139:chemically induced; D004347:Drug Interactions; D004374:Ductus Arteriosus, Patent / Q000188:drug therapy*; D005260:Female; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007674:Kidney Diseases / Q000139:chemically induced / Q000188:drug therapy*; D008297:Male; D009422:Nervous System Diseases / Q000139:chemically induced; D010372:Pediatrics; D011247:Pregnancy; D012127:Respiratory Distress Syndrome, Newborn / Q000139:chemically induced; D012871:Skin Diseases / Q000139:chemically induced; D013167:Spondylitis, Ankylosing / Q000188:drug therapy
D000893:Anti-Inflammatory Agents
Les anti-inflammatoires non steroidiens en pediatrie. (Deuxième partie).